Fate Therapeutics Stock Market Value
| FATE Stock | USD 3.95 0.09 2.23% |
| Symbol | Fate |
Fate Therapeutics Price To Book Ratio
Is Fate Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fate Therapeutics. If investors know Fate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Revenue Per Share 0.646 | Quarterly Revenue Growth (0.96) | Return On Assets (0.18) | Return On Equity (0.38) |
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fate Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fate Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fate Therapeutics.
| 04/01/2024 |
| 05/01/2024 |
If you would invest 0.00 in Fate Therapeutics on April 1, 2024 and sell it all today you would earn a total of 0.00 from holding Fate Therapeutics or generate 0.0% return on investment in Fate Therapeutics over 30 days. Fate Therapeutics is related to or competes with Atara Biotherapeutics, Sana Biotechnology, Caribou Biosciences, Arcus Biosciences, Intellia Therapeutics, Editas Medicine, and Crispr Therapeutics. Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for ca... More
Fate Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fate Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fate Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.79 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 36.47 | |||
| Value At Risk | (8.53) | |||
| Potential Upside | 9.89 |
Fate Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fate Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fate Therapeutics' standard deviation. In reality, there are many statistical measures that can use Fate Therapeutics historical prices to predict the future Fate Therapeutics' volatility.| Risk Adjusted Performance | 0.0097 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.1663 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fate Therapeutics Backtested Returns
Fate Therapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which denotes the company had a -0.14% return per unit of risk over the last 3 months. Fate Therapeutics exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fate Therapeutics' Coefficient Of Variation of 96080.27, downside deviation of 4.79, and Mean Deviation of 4.66 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0204, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Fate Therapeutics are expected to decrease at a much lower rate. During the bear market, Fate Therapeutics is likely to outperform the market. Fate Therapeutics has an expected return of -0.72%. Please make sure to confirm Fate Therapeutics semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Fate Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.85 |
Very good predictability
Fate Therapeutics has very good predictability. Overlapping area represents the amount of predictability between Fate Therapeutics time series from 1st of April 2024 to 16th of April 2024 and 16th of April 2024 to 1st of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fate Therapeutics price movement. The serial correlation of 0.85 indicates that around 85.0% of current Fate Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.85 | |
| Spearman Rank Test | 0.86 | |
| Residual Average | 0.0 | |
| Price Variance | 0.3 |
Fate Therapeutics lagged returns against current returns
Autocorrelation, which is Fate Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Fate Therapeutics' stock expected returns. We can calculate the autocorrelation of Fate Therapeutics returns to help us make a trade decision. For example, suppose you find that Fate Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Fate Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Fate Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Fate Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Fate Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Fate Therapeutics Lagged Returns
When evaluating Fate Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Fate Therapeutics stock have on its future price. Fate Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Fate Therapeutics autocorrelation shows the relationship between Fate Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Fate Therapeutics.
Regressed Prices |
| Timeline |
Fate Therapeutics Investors Sentiment
The influence of Fate Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Fate. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Fate Therapeutics' public news can be used to forecast risks associated with an investment in Fate. The trend in average sentiment can be used to explain how an investor holding Fate can time the market purely based on public headlines and social activities around Fate Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Fate Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Fate Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Fate Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Fate Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fate Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fate Therapeutics' short interest history, or implied volatility extrapolated from Fate Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Fate Therapeutics Correlation, Fate Therapeutics Volatility and Fate Therapeutics Alpha and Beta module to complement your research on Fate Therapeutics. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Fate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.